Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
LPXN
Introduction
Leupaxin is a protein that in humans is encoded by the LPXN gene.[1][2]
The product encoded by this gene is preferentially expressed in hematopoietic cells and is most homologous to the focal adhesion protein, paxillin. It may function in cell type-specific signaling by associating with PYK2, a member of focal adhesion kinase family. As a substrate for a tyrosine kinase in lymphoid cells, this protein may also function in, and be regulated by tyrosine kinase activity.[2]
References
References
- ↑ Lipsky BP, Beals CR, Staunton DE (Jun 1998). “Leupaxin is a novel LIM domain protein that forms a complex with PYK2”. J Biol Chem. 273 (19): 11709–13. doi:10.1074/jbc.273.19.11709. PMID 9565592.
- ↑ 2.0 2.1 “Entrez Gene: LPXN leupaxin”.
Further reading
Further reading
- Chew V, Lam KP (2007). “Leupaxin negatively regulates B cell receptor signaling”. J. Biol. Chem. 282 (37): 27181–91. doi:10.1074/jbc.M704625200. PMID 17640867.
- Sahu SN, Nunez S, Bai G, Gupta A (2007). “Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells”. Am. J. Physiol., Cell Physiol. 292 (6): C2288–96. doi:10.1152/ajpcell.00503.2006. PMID 17329398.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Tao WA, Wollscheid B, O’Brien R, et al. (2005). “Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry”. Nat. Methods. 2 (8): 591–8. doi:10.1038/nmeth776. PMID 16094384.
- Watanabe N, Amano N, Ishizuka H, Mashima K (2005). “Leupaxin binds to PEST domain tyrosine phosphatase PEP”. Mol. Cell. Biochem. 269 (1–2): 13–7. doi:10.1007/s11010-005-2149-6. PMID 15786712.
- Rush J, Moritz A, Lee KA, et al. (2005). “Immunoaffinity profiling of tyrosine phosphorylation in cancer cells”. Nat. Biotechnol. 23 (1): 94–101. doi:10.1038/nbt1046. PMID 15592455.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Brill LM, Salomon AR, Ficarro SB, et al. (2004). “Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry”. Anal. Chem. 76 (10): 2763–72. doi:10.1021/ac035352d. PMID 15144186.
- Gupta A, Lee BS, Khadeer MA, et al. (2003). “Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast”. J. Bone Miner. Res. 18 (4): 669–85. doi:10.1359/jbmr.2003.18.4.669. PMID 12674328.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Liu S, Thomas SM, Woodside DG, et al. (2000). “Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses”. Nature. 402 (6762): 676–81. doi:10.1038/45264. PMID 10604475.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.